Sandeep Laumas sold $702k of TIL
CFO and CBO at Instil Bio, Inc.. 30,000 shares at an average of $23.39, traded Sep 10, 2025, filed Sep 12, 2025.
Score components
- +22RoleCFO
- +21Trade size$702k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -20.2%, 3m -55.0%, 6m -65.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001789769-25-000087, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 10, 2025 | MOption exercise Common Stock | +17,000 | $11.60 | $197k | 17,000 | Sep 12, 2025 |
| Sep 10, 2025 | MOption exercise Common Stock | +13,000 | $12.68 | $165k | 30,000 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock | -17,539 | $23.04 | $404k | 12,461 | Sep 12, 2025 |
| Sep 10, 2025 | SOpen-market sale Common Stock | -12,461 | $23.88 | $298k | 0 | Sep 12, 2025 |
| Sep 10, 2025 | MOption exercise Employee Stock Option (right to buy)derivative | -17,000 | $0.00 | $0 | 17,000 | Sep 12, 2025 |
| Sep 10, 2025 | MOption exercise Employee Stock Option (right to buy)derivative | -13,000 | $0.00 | $0 | 30,000 | Sep 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.